Drug application
ERYPAR (ERYTHROMYCIN STEARATE)
Drugs@FDA ANDA 062032 · PARKE DAVIS
Key facts
| Drug name | ERYPAR |
|---|---|
| Active ingredients | ERYTHROMYCIN STEARATE |
| Application type | ANDA |
| Application number | 062032 |
| Company | PARKE DAVIS |
| Dosage forms | TABLET, ORAL |
| Strength | EQ 250MG BASE |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Aug 24, 1977 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.